Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

NCT00112918 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3451

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Capecitabine
DRUG: 5-Fluorouracil (5-FU)
DRUG: Leucovorin calcium
DRUG: Oxaliplatin

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]